MISXAPTK
Market cap869mUSD
Jun 17, Last price
11.80RUB
Name
Aptechnaya Set' 36,6 PAO
Chart & Performance
Profile
Public Joint-Stock Company Pharmacy Chain 36.6 operates pharmacies in Russia. Its pharmacies offer health and beauty products. The company serves customers under the 36.6, Romir, and Gorzdrav brands. Public Joint-Stock Company Pharmacy Chain 36.6 was founded in 1991 and is based in Moscow, Russia.
Valuation
Title RUB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | |||||||||
Revenues | 59,048,000 33.88% | 44,104,000 12.32% | |||||||
Cost of revenue | 40,285,000 | 30,056,000 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 18,763,000 | 14,048,000 | |||||||
NOPBT Margin | 31.78% | 31.85% | |||||||
Operating Taxes | 188,000 | (492,000) | |||||||
Tax Rate | 1.00% | ||||||||
NOPAT | 18,575,000 | 14,540,000 | |||||||
Net income | 223,000 -123.47% | (950,000) -4.23% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 10,281,000 | 15,892,000 | |||||||
Long-term debt | 35,703,000 | 25,110,000 | |||||||
Deferred revenue | (347,000) | (165,000) | |||||||
Other long-term liabilities | 347,000 | 165,000 | |||||||
Net debt | 45,853,000 | 39,835,000 | |||||||
Cash flow | |||||||||
Cash from operating activities | 6,595,000 | 3,227,000 | |||||||
CAPEX | (1,035,000) | (981,000) | |||||||
Cash from investing activities | (995,000) | 18,283,000 | |||||||
Cash from financing activities | (6,516,000) | (20,786,000) | |||||||
FCF | 17,298,000 | 33,881,000 | |||||||
Balance | |||||||||
Cash | 811,000 | 1,727,000 | |||||||
Long term investments | (680,000) | (560,000) | |||||||
Excess cash | |||||||||
Stockholders' equity | (51,012,000) | (51,235,000) | |||||||
Invested Capital | 76,127,000 | 74,992,000 | |||||||
ROIC | 24.58% | 17.27% | |||||||
ROCE | 73.69% | 58.72% | |||||||
EV | |||||||||
Common stock shares outstanding | 7,630,434 | 7,630,434 | |||||||
Price | 11.57 -16.76% | 13.90 -1.07% | |||||||
Market cap | 88,284,119 -16.76% | 106,063,030 10.91% | |||||||
EV | 134,137,119 | 145,898,030 | |||||||
EBITDA | 24,552,000 | 19,855,000 | |||||||
EV/EBITDA | 5.46 | 7.35 | |||||||
Interest | 4,241,000 | 3,239,000 | |||||||
Interest/NOPBT | 22.60% | 23.06% |